Commentary: When a choice is not an echo

Slides:

Advertisements

Similar presentations

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Advertisements

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

A comprehensive review of the PARTNER trial

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line? Thoralf M. Sundt, MD The Journal of Thoracic and Cardiovascular.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Marc R. Moon, MD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Form ever follows function

Skinning the cat: Another wrinkle for T-tube insertion

Bicuspid aortic valve aortopathy: One size fits all?

Commentary: Pursuit of the green jacket: Mastery of the long and short games Daniel P. Raymond, MD The Journal of Thoracic and Cardiovascular Surgery

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement Thomas.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement in intermediate-risk patients

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Get it right the first time

Torsten Doenst, MD, PhD, Markus Richter, MD

Commentary: Transaortic transcatheter aortic valve implantation: A route to be protected and not neglected Francesco Formica, MD, Gurmeet Singh, MD,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Choice of second pericardial drainage tube for posterior placement

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

A fate worse than death Jennifer S. Lawton, MD

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Hans-Joachim Schäfers, MD

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend G. Michael Deeb, MD, John Carroll, MD The Journal.

The harder one looks, the more one finds

Concomitant replacement of the ascending aorta is free—for some

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

Commentary: “Isn't cardiac surgery a team sport?”

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: All aboard the transcatheter express—Road map for surgeons to develop expertise in catheter-based treatment of structural heart disease Grayson.

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Commentary: Judgment day: Should you add atrial fibrillation ablation?

Toward a more rational approach in treating type B aortic dissection

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Avoiding coronary obstruction after transcatheter aortic valve replacement: Is it the skirt or what's inside that counts? Mohamad Alkhouli, MD, Vinay.

Commentary: The importance of being earnest and ... eclectic

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Commentary: When a choice is not an echo Craig R. Smith, MD The Journal of Thoracic and Cardiovascular Surgery Volume 158, Issue 2, Pages 376-377 (August 2019) DOI: 10.1016/j.jtcvs.2019.03.067 Copyright © 2019 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 The combined end point of death, stroke, and rehospitalization (Rehosp) in the PARTNER 3 (The Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis) trial. TAVR, Transcatheter aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2019 158, 376-377DOI: (10.1016/j.jtcvs.2019.03.067) Copyright © 2019 The American Association for Thoracic Surgery Terms and Conditions

The combined end point of death, stroke, and rehospitalization in the PARTNER 3 trial. The Journal of Thoracic and Cardiovascular Surgery 2019 158, 376-377DOI: (10.1016/j.jtcvs.2019.03.067) Copyright © 2019 The American Association for Thoracic Surgery Terms and Conditions